Agilent Technologies, Inc. (NYSE:A) Receives Average Rating of “Moderate Buy” from Brokerages

Agilent Technologies, Inc. (NYSE:A) has been given a consensus recommendation of “Moderate Buy” by the sixteen research firms that are presently covering the firm, Marketbeat.com reports. Three analysts have rated the stock with a hold rating, eleven have issued a buy rating and two have assigned a strong buy rating to the company. The average 12-month price objective among analysts that have updated their coverage on the stock in the last year is $161.20.

A has been the subject of a number of recent research reports. TD Cowen cut their target price on Agilent Technologies from $170.00 to $157.00 and set a “buy” rating for the company in a research note on Thursday, February 26th. Barclays lowered their price target on shares of Agilent Technologies from $165.00 to $150.00 and set an “overweight” rating on the stock in a report on Thursday, February 26th. The Goldman Sachs Group assumed coverage on shares of Agilent Technologies in a research note on Tuesday, December 9th. They issued a “buy” rating and a $170.00 price objective for the company. Weiss Ratings restated a “hold (c+)” rating on shares of Agilent Technologies in a research note on Monday, December 29th. Finally, Evercore raised Agilent Technologies from an “in-line” rating to an “outperform” rating and boosted their price target for the company from $155.00 to $160.00 in a research note on Monday, January 5th.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently modified their holdings of A. Hsbc Holdings PLC grew its position in Agilent Technologies by 2.3% during the 4th quarter. Hsbc Holdings PLC now owns 753,669 shares of the medical research company’s stock worth $102,642,000 after acquiring an additional 16,592 shares during the last quarter. World Investment Advisors raised its position in Agilent Technologies by 4.6% in the 4th quarter. World Investment Advisors now owns 5,813 shares of the medical research company’s stock valued at $791,000 after purchasing an additional 258 shares during the last quarter. Corient Private Wealth LLC boosted its stake in Agilent Technologies by 0.7% in the fourth quarter. Corient Private Wealth LLC now owns 186,265 shares of the medical research company’s stock worth $25,473,000 after purchasing an additional 1,347 shares in the last quarter. Mengis Capital Management Inc. grew its holdings in shares of Agilent Technologies by 4.9% during the fourth quarter. Mengis Capital Management Inc. now owns 15,946 shares of the medical research company’s stock worth $2,170,000 after purchasing an additional 742 shares during the last quarter. Finally, Rehmann Capital Advisory Group grew its holdings in shares of Agilent Technologies by 7.1% during the fourth quarter. Rehmann Capital Advisory Group now owns 2,134 shares of the medical research company’s stock worth $292,000 after purchasing an additional 141 shares during the last quarter.

Agilent Technologies Stock Down 0.0%

A stock opened at $115.44 on Friday. Agilent Technologies has a twelve month low of $96.43 and a twelve month high of $160.27. The company has a market cap of $32.62 billion, a PE ratio of 25.48, a price-to-earnings-growth ratio of 2.43 and a beta of 1.30. The business’s 50-day simple moving average is $121.28 and its 200 day simple moving average is $134.44. The company has a quick ratio of 1.59, a current ratio of 2.07 and a debt-to-equity ratio of 0.44.

Agilent Technologies (NYSE:A) last posted its quarterly earnings results on Wednesday, February 25th. The medical research company reported $1.36 EPS for the quarter, missing the consensus estimate of $1.37 by ($0.01). Agilent Technologies had a net margin of 18.26% and a return on equity of 24.49%. The firm had revenue of $1.80 billion during the quarter, compared to analyst estimates of $1.81 billion. During the same period last year, the company earned $1.31 EPS. The company’s revenue was up 7.0% on a year-over-year basis. Agilent Technologies has set its FY 2026 guidance at 5.900-6.040 EPS and its Q2 2026 guidance at 1.390-1.420 EPS. On average, research analysts anticipate that Agilent Technologies will post 5.58 earnings per share for the current year.

Agilent Technologies Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Wednesday, April 22nd. Stockholders of record on Tuesday, March 31st will be issued a $0.255 dividend. The ex-dividend date of this dividend is Tuesday, March 31st. This represents a $1.02 annualized dividend and a dividend yield of 0.9%. Agilent Technologies’s dividend payout ratio is presently 22.52%.

About Agilent Technologies

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.